BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37240117)

  • 1. The Role of Natural Products in the Improvement of Cancer-Associated Cachexia.
    Han Y; Kim HI; Park J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Extract of
    Han YH; Mun JG; Jeon HD; Yoon DH; Choi BM; Kee JY; Hong SH
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33086629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
    Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
    Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
    Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
    Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
    Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
    Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
    BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
    Hanada K; Fukasawa K; Hinata H; Imai S; Takayama K; Hirai H; Ohfusa R; Hayashi Y; Itoh F
    Cancer Sci; 2022 Oct; 113(10):3547-3557. PubMed ID: 35849084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
    Dolly A; Dumas JF; Servais S
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cachexia: molecular mechanism and pharmacological management.
    Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
    Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
    Arneson PC; Doles JD
    Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
    Talbert EE; Guttridge DC
    Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
    Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of muscle wasting by gintonin in cancer cachexia.
    Wijaya YT; Setiawan T; Sari IN; Nah SY; Kwon HY
    Neoplasia; 2021 Dec; 23(12):1307-1317. PubMed ID: 34798386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies.
    Martin A; Freyssenet D
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):252-273. PubMed ID: 33783983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.